Please join the PFF and industry representatives for the PFF CTI Webinar Series. You will learn about various research studies underway to help find new treatments for pulmonary fibrosis and interstitial lung disease.

CTI Webinar Series June Presenters

A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis (ASPIRE)

• Trial Sponsor: Vicore Pharma AB
• Speaker: James Nolin, PhD; Senior Clinical Science Liaison at Vicore Pharma AB

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

• Trial Sponsor: Boehringer Ingelheim
• Speaker: Thomas Porter, MBA, MPH; Director, Clinical Development Lead at Boehringer Ingelheim

PFF Community Registry

DISCLAIMER: Participation in the CTI Webinar Series and references to specific commercial entities (companies) or products do not reflect endorsement by the PFF. The PFF does not endorse or promote any products or services participants discuss in the CTI Webinar Series, and participants cannot suggest otherwise. Please note that any information contained in this presentation is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice. Always consult your personal physician or health care provider to determine if a clinical trial is right for you.